Aurora Cannabis (TSX: ACB) delivered net revenue of $86.0 million, including record international medical cannabis net revenue of $61.4 million, representing a 44% YoY increase. The company generated adjusted EBITDA of $14.0 million, with free cash flow1 outflow improving by $22.4 million. Aurora also maintains strong balance sheet with $133.0 million of cash, cash equivalents2 and short-term investments with no debt.
Click here for the full story.
Top cannabis news stories
1 | Curaleaf (TSX: CURA) issues statement regarding alternative proposal for Aurora Cannabis
2 | Biorem (TSXV: BRM) reports record third-quarter earnings of $ 2.7 million and $0.16 eps – revenue increases 48% over same period in prior year
3 | Cronos Group Inc. (TSX: CRON) organically achieves record net revenue, gross profit, and Adjusted EBITDA while reducing share count
4 | Auxly (TSX: XLY) to report third quarter 2026 financial results on November 12, 2026
Top Cannabis Stocks Oct. 30 to Nov. 05, 2026
1. T.CURA | 8,532 views | Curaleaf Holdings Inc.
2. T.TLRY | 6,338 views | Tilray Brands Inc.
3. T.ACB | 4,371 views | Aurora Cannabis Inc.
4. T.LABS| 3,396 views | Medipharm Labs Corp.
5. V.HIP | 2,256 views | Newstrike Brands Ltd.
6. T.APHA | 2,180 views | Aphria Inc.
Join the discussion: Find out what investors are saying about cannabis stocks and make sure to explore the rest of Stockhouse’s stock forums and message boards.
